ALPHAPORT.AI
🇺🇸NewGenIvf Group LtdNIVF
USDUSD
SectorHealth CareIndustryProviders
Management
Wing Fung Siu
CEO

Company information

Ticker
NIVF
Country
United States
Sector
Health Care
Industry
Providers

NewGenIvf Group Business Summary

NewGenIvf Group Ltd (NIVF) operates a diversified business model that has recently pivoted from a pure-play assisted reproductive services (ARS) provider into a tech-forward holding company. The firm generates revenue through service fees from its core fertility clinics in Thailand, Cambodia, and Kyrgyzstan, which offer in-vitro fertilization (IVF), egg donation, and surrogacy. Under its 2026 strategic expansion, the company has added high-margin revenue streams including percentage-based commissions from Real World Asset (RWA) tokenization via its NewGenDigital division and profit-sharing from luxury real estate developments in the UAE through NewGenProperty. NIVF competes directly with healthcare and medical technology firms such as Agape ATP (ATPC), Aclarion (ACON), and Digital Health Acquisition (DHAC). Relative to these peers, NIVF distinguishes itself by integrating blockchain-based digital asset management with traditional healthcare to create a multi-jurisdictional, technology-driven ecosystem. The company was co-founded in 2019 by Chairman and CEO Wing Fung (Alfred) Siu and Chief Marketing Officer Hei Yue (Tina) Fong. Siu, a Stanford University alumnus with a background in science and engineering, leads the group's strategic direction, while Fong brings extensive marketing expertise from Indiana University. The leadership team was further strengthened in late 2024 by the appointment of CFO Ho Fai Chung, a U.S. Certified Public Accountant with over 30 years of regional financial experience, and in early 2026 by Web3 specialist Joshua Chu, who serves as Senior Counsel to spearhead the group's tokenization initiatives. The Board of Directors includes independent members such as Chun Wa Tam and Florianna Ann Chi Wan Chan, the latter of whom brings two decades of luxury hospitality and project management experience. As of early 2026, the company maintains a significant institutional ownership base of approximately 66%, reflecting investor interest in its diversified tech-healthcare model.

Updated 2026-07-31 · US SEC company filings
Financial Metric TrendsQuarterly⌄
Business Overview is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.